End Of Schultz Era Looms For Teva

CEO Kåre Schultz Unlikely To Renew Contract Past November 2023, Company Confirms

Kare Schultz
Kåre Schultz has been president and CEO of Teva since late 2017 • Source: Teva

More from Leadership

More from Generics Bulletin